151 related articles for article (PubMed ID: 7656780)
1. [Radioimmunoimaging (RII) and radioimmunotherapy (RIT) of human primary hepatic cancer (hPHC) with anti-PHC monoclonal antibody in tumor bearing nude mice].
Shi L; Wu M; Chen H
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):20-3. PubMed ID: 7656780
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunologic targeting and therapy with antihuman primary hepatic cancer monoclonal antibodies (Hepama I) in patients].
Shi L; Wu M; Chen H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):146-9. PubMed ID: 10743083
[TBL] [Abstract][Full Text] [Related]
3. [The experimental study of anti-human AFP variant McAb in radioimmuno-detection and radioimmuno-therapy of human hepatocellular carcinoma model in nude mice].
Liu Y; Wu MC; Qian GX
Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):650-3. PubMed ID: 7539734
[TBL] [Abstract][Full Text] [Related]
4. Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Xie H; Yao Z
J Cancer Res Clin Oncol; 1998; 124(5):275-80. PubMed ID: 9645459
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
Zeng ZC; Tang ZY; Xie H; Liu KD; Lu JZ; Chai XJ; Wang GF; Yao Z; Qian JM
J Cancer Res Clin Oncol; 1993; 119(5):257-9. PubMed ID: 8382704
[TBL] [Abstract][Full Text] [Related]
6. Enhanced radioimmunotherapeutic efficacy of a monoclonal antibody cocktail against SMMC-7721 human hepatocellular carcinoma.
Song YQ; Wang GF; Dai XL; Xie H
Cell Res; 1998 Sep; 8(3):241-7. PubMed ID: 9791737
[TBL] [Abstract][Full Text] [Related]
7. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Cai XJ; Xie H
Cancer Immunol Immunother; 1994 Nov; 39(5):332-6. PubMed ID: 7987865
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunoimaging of hepatocellular carcinoma with 131I labeled antihepatoma monoclonal antibody Fab fragment].
Sui Y; He F; Chen Z
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):537-9. PubMed ID: 10923467
[TBL] [Abstract][Full Text] [Related]
9. Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer.
Chen J; Wu H; Han D; Xie C
Cancer Lett; 2006 Jan; 231(2):169-75. PubMed ID: 16399221
[TBL] [Abstract][Full Text] [Related]
10. [Radioimmunoimaging with monoclonal antibody to HBV X protein in nude mice bearing human hepatocellular carcinoma].
Li J; Tang ZY; Liu KD
Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):11-4. PubMed ID: 8033739
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
[TBL] [Abstract][Full Text] [Related]
14. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
15. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
17. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
18. Observation of changes in peripheral T-lymphocyte subsets by flow cytometry in patients with liver cancer treated with radioimmunotherapy.
Zeng ZC; Tang ZY; Liu KD; Yu YQ; Yang BH; Cai XJ; Xie H; Cao SL
Nucl Med Commun; 1995 May; 16(5):378-85. PubMed ID: 7659390
[TBL] [Abstract][Full Text] [Related]
19. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma].
DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714
[TBL] [Abstract][Full Text] [Related]
20. The effect of radioimmunotherapy using murine monoclonal antibody KIS1 on esophageal squamous cell carcinoma-bearing nude mice.
Fujii T; Yamana H; Toh Y; Toh U; Fujita H; Shirouzu K; Morimatsu M
Surg Today; 1997; 27(11):1026-34. PubMed ID: 9413055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]